DJIA 17,745.38 -0.60 0.00%
NASDAQ 5,149.49 20.71 0.40%
S&P 500 2,111.58 2.95 0.14%
market minute promo

Biogen Idec (NASDAQ: BIIB)

321.44 4.44 (1.40%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BIIB $321.35 1.37%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $319.57
Previous Close $317.00
Daily Range $312.70 - $322.35
52-Week Range $290.85 - $480.18
Market Cap $75.6B
P/E Ratio 21.40
Dividend (Yield) $0.00 (0.0%)
Volume 1,310,872
Average Daily Volume 2,587,773
Current FY EPS $16.01

Sector

Healthcare

Industry

Drug Makers

Biogen Idec (BIIB) Description

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website: http://www.biogenidec.com/

News & Commentary

Attention New Biotech Investors: Biogen Inc's Recent Weakness Is Your Opportunity

Biogen's stock has fallen hard recently based on slower than expected earnings growth of Tecfidera. Still, the company boasts a number of billion dollar drugs and a strong pipeline that make it an ideal choice for new biotech investors.

Today's Market: Biotech Earnings Remain Strong, Apple's Next Revamped Product

The Zacks Analyst Blog Highlights: Biogen, AbbVie, Regeneron, Amgen and XOMA - Press Releases

3 Stocks Pushing The Drugs Industry Lower

Gilead Q2 Earnings: KAPOW! BAM! BOOM! (Yes, That Good)

The Zacks Analyst Blog Highlights: Biogen, Ligand Pharmaceuticals, bluebird bio, Regeneron Pharmaceu

The Zacks Analyst Blog Highlights: Biogen, Ligand Pharmaceuticals, bluebird bio, Regeneron Pharmaceuticals and Exelixis - Press Releases

Is More M&A On The Way For Large-Cap Biotechs?

ISIS Pharmaceuticals: Another Entry Point

Tuesday 7/28 Insider Buying Report: BIIB, MJN

InsiderInsights.com Daily Round Up 7/27/15: Allegheny Technologies, Fibrocell Science, Mead Johnson

InsiderInsights.com Daily Round Up 7/27/15: Allegheny Technologies, Fibrocell Science, Mead Johnson Nutrition, Mobile Mini

See More BIIB News...

BIIB's Top Competitors

BIIB $321.44 (1.40%)
Current stock: BIIB
AMGN $178.14 (3.76%)
Current stock: AMGN
GILD $118.33 (0.36%)
Current stock: GILD
$0.00 (0.00%)
Current stock: